Connor, Clark & Lunn Investment Management Ltd.
Position in MEDP — Medpace Holdings, Inc.
CIK 1596800
VANCOUVER, A1
Position in MEDP
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$64,747,859
-$15,206,388 QoQ
Shares Held
134,838
-5.3% QoQ
Ownership
0.472%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $206,312,128 across 18 Diagnostics & Research names. MEDP ranks #1 (31.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
This page
|
134,838 | $64,747,859 | |
| 2 | ILMN |
Illumina, Inc.
|
202,742 | $24,989,978 | |
| 3 | DHR |
Danaher Corp /De/
|
129,426 | $24,539,169 | |
| 4 | GH |
Guardant Health, Inc.
|
254,788 | $23,534,767 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
54,570 | $9,413,325 | |
| 6 | CSTL |
Castle Biosciences Inc
|
377,082 | $9,257,363 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
649,627 | $9,016,822 | |
| 8 | NEO |
Neogenomics Inc
|
938,052 | $6,960,345 |
All Filings in MEDP
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $64,747,859 | 134,838 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $79,954,247 | 142,356 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $66,120,461 | 128,599 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $49,857,288 | 158,852 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $26,375,794 | 86,566 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $21,733,157 | 65,416 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $8,820,665 | 26,425 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,919,632 | 4,661 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,628,995 | 6,505 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,460,516 | 8,027 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $4,823,229 | 19,920 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,353,733 | 13,964 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $568,663 | 3,024 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $5,406,684 | 25,454 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,325,548 | 33,884 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,754,866 | 31,769 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,612,230 | 22,081 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,482,569 | 25,191 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,068,573 | 21,495 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,644,425 | 9,310 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||